Mdr3 gene mutation in preterm infants with parenteral nutrition-associated cholestasis

Area of Science:

• Genetics
• Pediatrics
• Hepatology

Background:

• Parenteral nutrition-associated cholestasis (PNAC) is a serious complication in preterm infants.
• The genetic factors contributing to PNAC are not fully understood.
• Multidrug resistance 3 (Mdr3) plays a crucial role in bile transport.

Purpose of the Study:

• To investigate the association between multidrug resistance 3 (Mdr3) gene mutations and the development of PNAC in preterm infants.
• To identify specific Mdr3 gene mutations that may predispose infants to PNAC.
• To explore the potential of Mdr3 gene mutations as a genetic marker for PNAC.

Main Methods:

• Genomic DNA was extracted from 76 preterm infants with PNAC and 80 preterm infants without PNAC.
• The 28 exons of the Mdr3 gene were amplified using polymerase chain reaction.
• Allele and genotype frequencies of Mdr3 mutations were compared between PNAC and non-PNAC groups.

Main Results:

• Four specific Mdr3 gene mutations (c.1031G>A, c.3347G>A, c.485T>A, and c.2793_2794insA) were identified in the PNAC group.
• The frequency of these Mdr3 mutations was significantly higher in infants with PNAC compared to those without (21.05% vs. 1.25%, p < 0.05).
• Allele and genotype frequencies of c.1031G>A, c.3347G>A, and c.485T>A were significantly elevated in the PNAC group.

Conclusions:

• Mdr3 gene mutations, including c.2793_2794insA, c.1031G>A, c.3347G>A, and c.485T>A, are significantly associated with PNAC in preterm infants.
• These Mdr3 mutations may represent a genetic predisposition to developing PNAC.
• Further research into Mdr3 gene mutations could lead to improved diagnostics and management of PNAC.